Stock Research for BAYRY

BAYRY

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

BAYRY Stock Chart & Research Data

The BAYRY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BAYRY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


BAYRY Due diligence Resources & Stock Charts

The BAYRY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BAYRY Detailed Price Forecast - CNN Money CNN View BAYRY Detailed Summary - Google Finance
Yahoo View BAYRY Detailed Summary - Yahoo! Finance Zacks View BAYRY Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View BAYRY Trends & Analysis - Trade-Ideas Barrons View BAYRY Major Holders - Barrons
NASDAQ View BAYRY Call Transcripts - NASDAQ Seeking View BAYRY Breaking News & Analysis - Seeking Alpha
Spotlight View BAYRY Annual Report - CompanySpotlight.com OTC Report View BAYRY OTC Short Report - OTCShortReport.com
TradeKing View BAYRY Fundamentals - TradeKing Charts View BAYRY SEC Filings - Bar Chart
WSJ View Historical Prices for BAYRY - The WSJ Morningstar View Performance/Total Return for BAYRY - Morningstar
MarketWatch View the Analyst Estimates for BAYRY - MarketWatch CNBC View the Earnings History for BAYRY - CNBC
StockMarketWatch View the BAYRY Earnings - StockMarketWatch MacroAxis View BAYRY Buy or Sell Recommendations - MacroAxis
Bullish View the BAYRY Bullish Patterns - American Bulls Short Pains View BAYRY Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View BAYRY Stock Mentions - StockTwits PennyStocks View BAYRY Stock Mentions - PennyStockTweets
Twitter View BAYRY Stock Mentions - Twitter Invest Hub View BAYRY Investment Forum News - Investor Hub
Yahoo View BAYRY Stock Mentions - Yahoo! Message Board Seeking Alpha View BAYRY Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for BAYRY - SECform4.com Insider Cow View Insider Transactions for BAYRY - Insider Cow
CNBC View BAYRY Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BAYRY - OTC Markets
Yahoo View Insider Transactions for BAYRY - Yahoo! Finance NASDAQ View Institutional Holdings for BAYRY - NASDAQ


Stock Charts

FinViz View BAYRY Stock Insight & Charts - FinViz.com StockCharts View BAYRY Investment Charts - StockCharts.com
BarChart View BAYRY Stock Overview & Charts - BarChart Trading View View BAYRY User Generated Charts - Trading View




Latest Financial News for BAYRY


Bayer hemophilia treatment wins thumbs-up from EU panel
Posted on Friday September 21, 2018

Bayer AG's long-acting treatment for hemophilia A has won a recommendation from a European Medicines Agency (EMA) panel for the treatment of the rare genetic disorder in which blood does not clot easily. While final approvals are up to the European Commission, it generally follows recommendations from the Committee for Medicinal Products for Human Use (CHMP) and endorses them within a couple of months. The U.S. Food and Drug Administration last month approved https://in.reuters.com/article/us-bayer-fda/bayers-hemophilia-a-treatment-gets-u-s-fda-approval-idINKCN1LF17B the injection for previously treated patients and adolescents aged 12 years or older, judging it helped replace the reduced or missing protein, factor VIII, required to form blood clots.


Progenics Pharma's Stock Down on Dismal Phase III Study Data
Posted on Thursday September 20, 2018

Progenics Pharmaceuticals' (PGNX) shares down on disappointing results from phase III study evaluating imaging agent, 1404, for prostate cancer detection.


[$$] Bayer Steps Up Legal Fight Over Weed Killer Blamed for Cancer
Posted on Wednesday September 19, 2018

Bayer AG is stepping up the legal defense of its flagship weedkiller, after a recent verdict in a case alleging the chemical causes cancer sent shares down sharply and raised the prospect of costly plaintiff payouts. The German company on Tuesday said it wants a California state court judge to overturn the jury’s verdict, order a new trial or reduce damages, according to a court filing. The $289 million award granted in August came in one of the first of thousands of cases filed by gardeners, farmers and others claiming Bayer’s Roundup herbicide gave them cancer.


Monsanto asks judge to throw out $289M award in cancer suit
Posted on Wednesday September 19, 2018

SAN FRANCISCO (AP) — Agribusiness company Monsanto has asked a San Francisco judge to throw out a jury's $289 million award to a former school groundskeeper who said the company's Roundup weed killer left him dying of cancer.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.